TriangleNCT00833833 · MORE INFO
Limitations, agreements, and source contact
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- certain Agreement
- other Details
- * Multicenter publication must include input from investigators and Celgene, and has priority over subset (single center) publication, for 1 year after study completion. * Investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. Celgene has 45 days to review and comment on draft manuscript/presentation, and may ask for an additional delay (not to exceed 90 days total) to address intellectual property issues.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- clinicaltrialdisclosure@celgene.com
- organization
- Celgene Corporation
- phone
- 1-888-260-1599
- title
- Associate Director, Clinical Trials Disclosure
Complete source fields
- certain Agreement
- other Details
- * Multicenter publication must include input from investigators and Celgene, and has priority over subset (single center) publication, for 1 year after study completion. * Investigators have publication right after multicenter publication is complete (or 1 year after study completion), whichever is first. Celgene has 45 days to review and comment on draft manuscript/presentation, and may ask for an additional delay (not to exceed 90 days total) to address intellectual property issues.
- pi Sponsor Employee
- false
- restriction Type
- OTHER
- restrictive Agreement
- true
- point Of Contact
- clinicaltrialdisclosure@celgene.com
- organization
- Celgene Corporation
- phone
- 1-888-260-1599
- title
- Associate Director, Clinical Trials Disclosure
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice